Effect of amubarvimab-romlusevimab for treatment of severe COVID-19 in intensive care units: a retrospective cohort study

Published: 2 April 2024| Version 1 | DOI: 10.17632/myzc6gsmh9.1
Contributor:
Peng Qu

Description

Effect of amubarvimab-romlusevimab for treatment of severe COVID-19 in intensive care units: a retrospective cohort study

Files

Institutions

Southern Medical University Nanfang Hospital

Categories

Clinical Medicine

Licence